Key Highlights
•
A new brain imaging biomarker, called the DLB-related pattern (DLBRP), can accurately diagnose dementia with Lewy bodies (DLB) and even detect the disease in its early, pre-dementia stages. This tool helps doctors distinguish DLB from Alzheimer’s disease, leading to more accurate diagnoses and better-targeted care for patients.
Source →
•
A long-term study shows that a non-drug sleep intervention for people with dementia living at home significantly improved sleep disturbances for up to two years. This finding provides a practical and lasting treatment option for a common and distressing problem faced by individuals with dementia and their caregivers.
Source →
•
A large study from Japan found that newer insomnia drugs called dual orexin receptor antagonists are more likely to be stopped by patients than older benzodiazepine drugs after several months of use. This suggests the newer medications may be a useful tool for treating insomnia without the same long-term dependency risks as traditional sleep aids.
Source →
•
Researchers have identified specific small RNA molecules derived from tRNA that are associated with necrotizing enterocolitis, a serious intestinal disease in newborns. Discovering these molecular markers is a crucial first step toward developing new diagnostic tests and understanding the biology of this dangerous condition.
Source →
•
A study finds that both physical activity and sedentary behavior have significant effects on the risk of developing cardiovascular and respiratory diseases. This reinforces the public health message that moving more and sitting less are directly linked to better long-term heart and lung health.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
